Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent drug approvals and robust pipeline, initiatives from government agencies in pharmaceutical industry, and rising awareness about microbial diseases.
The antimicrobial therapeutics market is segmented as below:
By Application
- Antiviral
- Antibacterial
- Antifungal
- Antiparasitic
By End-user
- Pharmacies
- Hospitals and clinics
- Research and academic institutes
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the antimicrobial therapeutics market covers the following areas:
- Antimicrobial therapeutics market sizing
- Antimicrobial therapeutics market forecast
- Antimicrobial therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global antimicrobial therapeutics market: AbbVie Inc., Astellas Pharma Inc., Bavarian Nordic AS, Biocidium Biopharmaceuticals Inc., Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Corp., Novartis AG, Novavax Inc., Pfizer Inc., Sanofi SA, and Wockhardt Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in research and development of therapeutic vaccines."
According to the report, one of the major drivers for this market is the recent drug approvals and robust pipeline.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- Bavarian Nordic AS
- Biocidium Biopharmaceuticals Inc.
- Bristol Myers Squibb Co.
- Cadila Pharmaceuticals Ltd.
- CSL Ltd.
- Emergent BioSolutions Inc.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Mitsubishi Corp.
- Novartis AG
- Novavax Inc.
- Pfizer Inc.
- Sanofi SA
- Wockhardt Ltd.